Loading...
| A03627 | Pages: NA | Dec 2021 | 4438 Views | | |
| Author(s) : NA | Tables: NA | Charts: NA |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Global Biosimilar Testing And Development Services Market
Request Now !A biosimilar is a biological product that is almost an identical copy of the original product manufactured by a different company. They are the accepted version of an original product that can be used when the original products patent expires.
Factors such as increase in demand for biosimilar products, patent expiration of original drugs, and increase R&D investments on biosimilar testing and development services drive the market growth. However, shortage of skilled professionals and expensive development procedure of biosimilar drugs restrain the market growth. Moreover, comparatively lower cost of biosimilar than original drugs and untapped market opportunities in emerging nations such as China, Brazil, and India is expected to fuel the market growth.
The global biosimilar testing and development services market is segmented on the basis of clinical assays, comparability testing, and region. On the basis of clinical assays, it is divided into PK assay, tiered immunogenicity testing, and NAb assays. On the basis of comparability testing, it is classified into effector binding, ELISA, kinetic binding assays, and ADCC & CDC cell-based assays. Effector binding are further sub-segmented into FcRI (CD64), FcRII (CD32a), FcRIII (CD16a), and FcRn. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, UK, France, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, India, Australia, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, Saudi Arabia, South Africa, and rest of LAMEA).
Key players in the market include Eurofins Scientific, SGS S.A., Charles River Laboratories International Inc., Pharmaceutical Product Development, LLC, Exova Group plc, Source BioScience plc, Intertek Group plc, Medistri SA, Pace Analytical Services Inc., and Sigma-Aldrich Co. LLC.
Key Benefits
CHAPTER 1 INTRODUCTION
1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY
1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools & models
CHAPTER 2 EXECUTIVE SUMMARY
2.1. CXO PERSPECTIVE
CHAPTER 3 MARKET OVERVIEW
3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS
3.2.1. Top investment pockets
3.2.2. Top winning strategies
3.3. MARKET SHARE ANALYSIS, 2016
3.4. PORTER’S FIVE FORCES ANALYSIS
3.4.1. MARKET DYNAMICS
3.4.2. Drivers
3.4.3. Restraints
3.4.4. Opportunities
CHAPTER 4 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET, BY CLINICAL ASSAYS
4.1. OVERVIEW
4.1.1. Market size and forecast
4.2. PK ASSAYS
4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast
4.3. TIERED IMMUNOGENICITY TESTING
4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast
4.4. NAB ASSAYS
4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast
CHAPTER 5 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET, BY COMPARABILITY TESTING
5.1. OVERVIEW
5.1.1. Market size and forecast
5.2. EFFECTOR BINDING BIACORE
5.2.1. FcγRI (CD64)
5.2.2. FcγRII (CD32a)
5.2.3. FcγRIII (CD16a)
5.2.4. FcRn
5.2.5. Market size and forecast
5.3. C1Q BINDING BY ELISA
5.3.1. Market size and forecast
5.4. KINETIC BINDING ASSAYS BY BIACORE
5.4.1. Market size and forecast
5.5. ADCC AND CDC ASSAYS CELL BASED ASSAYS
5.5.1. Market size and forecast
CHAPTER 6 GLOBAL BIOSIMILAR TESTING AND DEVELOPMENT SERVICES MARKET, BY REGION
6.1. OVERVIEW
6.2. NORTH AMERICA
6.2.1. Key market trends
6.2.2. Key growth factors and opportunities
6.2.3. Market size and forecast
6.2.3.1. U.S. market size and forecast
6.2.3.2. Canada market size and forecast
6.2.3.3. Mexico market size and forecast
6.2.4. North America Global Biosimilar Testing and Development Services Market, by Clinical Assays
6.2.5. North America Global Biosimilar Testing and Development Services Market, by Comparability Testing
6.3. EUROPE
6.3.1. Key market trends
6.3.2. Key growth factors and opportunities
6.3.3. Market size and forecast
6.3.3.1. Germany market size and forecast
6.3.3.2. France market size and forecast
6.3.3.3. UK market size and forecast
6.3.3.4. Italy market size and forecast
6.3.3.5. Spain market size and forecast
6.3.3.6. Rest of Europe market size and forecast
6.3.4. Europe Global Biosimilar Testing and Development Services Market, by Clinical assays
6.3.5. Europe Global Biosimilar Testing and Development Services Market, by Comparability Testing
6.4. ASIA-PACIFIC
6.4.1. Key market trends
6.4.2. Key growth factors and opportunities
6.4.3. Market size and forecast
6.4.3.1. Japan market size and forecast
6.4.3.2. China market size and forecast
6.4.3.3. Australia market size and forecast
6.4.3.4. India market size and forecast
6.4.3.5. South Korea market size and forecast
6.4.3.6. Rest of Asia-Pacific market size and forecast
6.4.4. Asia-Pacific Global Biosimilar Testing and Development Services Market, by Clinical Assays
6.4.5. Asia-Pacific Global Biosimilar Testing and Development Services Market, by Comparability Testing
6.5. LAMEA
6.5.1. Key market trends
6.5.2. Key growth factors and opportunities
6.5.3. Market size and forecast
6.5.3.1. Brazil market size and forecast
6.5.3.2. Saudi Arabia market size and forecast
6.5.3.3. South Africa market size and forecast
6.5.3.4. Rest of LAMEA market size and forecast
6.5.4. LAMEA Global Biosimilar Testing and Development Services Market, by Clinical Assays
6.5.5. LAMEA Global Biosimilar Testing and Development Services Market, by Comparability Testing
CHAPTER 7 COMPANY PROFILES
7.1. EUROFINS SCIENTIFIC
7.1.1. Operating business segments
7.1.2. Business performance
7.1.3. Key strategic moves and developments
7.2. SGS SA
7.2.1. Operating business segments
7.2.2. Business performance
7.2.3. Key strategic moves and developments
7.3. CHARLES RIVER LABORATORIES INTERNATIONAL INC.
7.3.1. Operating business segments
7.3.2. Business performance
7.3.3. Key strategic moves and developments
7.4. PHARMACEUTICAL PRODUCT DEVELOPMENT, LLC.
7.4.1. Operating business segments
7.4.2. Business performance
7.4.3. Key strategic moves and developments
7.5. EXOVA GROUP PLC.
7.5.1. Operating business segments
7.5.2. Business performance
7.5.3. Key strategic moves and developments
7.6. SOURCE BIOSCIENCE PLC.
7.6.1. Operating business segments
7.6.2. Business performance
7.6.3. Key strategic moves and developments
7.7. INTERTEK GROUP PLC.
7.7.1. Operating business segments
7.7.2. Business performance
7.7.3. Key strategic moves and developments
7.8. MEDISTRI SA
7.8.1. Operating business segments
7.8.2. Business performance
7.8.3. Key strategic moves and developments
7.9. PACE ANALYTICAL SERVICES INC.
7.9.1. Operating business segments
7.9.2. Business performance
7.9.3. Key strategic moves and developments
7.10. SIGMA-ALDRICH CO. LLC
7.10.1. Operating business segments
7.10.2. Business performance
7.10.3. Key strategic moves and developments
Clients can easily download both quantitative as well as
qualitative reports in PDF and excel formats.
Start reading.
This Report and over 13,000+ thousand more Reports, Available with Avenue Library. T&C*.
10%
Discount
10%
Discount
10%
Discount
10%
Discount
Enterprise
License/PDF
10%
Discount
Buy Now *Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
